Inhibikase Therapeutics, Inc.

Nasdaq:IKT

Biological Products, (No Diagnostic Substances)·WILMINGTON, DE

Governanceproxy statements · beneficial ownership

Proxy Statements

21 shown

Filed	Form	Description
6/12/25	DEFA14A	DEFA14A	→
5/12/25	DEFA14A	DEFA14A	→
5/12/25	DEF 14A	DEF 14A	→
5/2/25	PRE 14A	PRE 14A	→
11/18/24	DEF 14A	DEF 14A	→
11/8/24	PRE 14A	PRE 14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
1/7/26	4	4	→
1/7/26	4	4	→
1/7/26	4	4	→
↓